Naxitamab

Category: Cancer



Naxitamab Overview

Naxitamab, sold under the brand name Danyelza, is a monoclonal antibody medication used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) for people one year of age and older with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow demonstrating a partial response, minor response, or stable disease to prior therapy.[2][3] The most common adverse reactions include infusion-related reactions, pain, tachycardia, vo...

Read more Naxitamab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Naxitamab

Recent Naxitamab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Naxitamab
  • Solution: 40mg/10ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Naxitamab or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 January 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA